Emibetuzumab

Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P99192
Product Details
HY-P99192

Data sheet

Size
Multiple sizes
Reactivity
c-Met/HGFR
Application
Cancer-Kinase/protease
CAS
1365287-97-3

Menu

Settings